Background and Purpose: JV
N itric oxide synthase(s) is known to exist in many cell types, and it plays an important role in the transduction mechanism for stimulation of the soluble guanylate cyclase and formation of guanosine 3',5'-cyclic monophosphate (cyclic GMP). 1 In vascular endothelial and smooth muscle cells, the activity of nitric oxide synthase can be inhibited by 7V
G -substituted analogues of L-arginine (Af G -monomethyl-L-arginine [L-NMMA] and JV G -nitro-L-arginine [L-NNA]). 2 " 5 Inactivation of nitric oxide synthase(s) by L-arginine analogues causes contraction of isolated arteries and an increase in peripheral vascular resistance in vivo. 67 These findings suggest that the basal activity of nitric oxide synthase plays a key role in governing the resting tone of the vasculature.
In the canine basilar artery, contractions to L-NMMA are for the most part mediated by inactivation of the basal activity of nitric oxide synthase in endothelial cells. 89 However, we have also detected a small but significant endothelium-independent component of the contractile effect to L-NMMA. The present study was designed to analyze the mechanism of direct vascular smooth muscle contractions induced by L-NMMA and to determine if they are mediated by inactivation of the basal activity of nitric oxide synthase. The effects and mechanisms of action of the pharmacological tools used to study contractions to L-NMMA are described in Figure 1 . and without endothelium and in the presence of 10" 5 M indomethacin. Each ring was connected to an isometric force transducer (MTC-2, Gould, Glen Burnie, Md.) and suspended in an organ chamber filled with 25 ml of control solution at 37°C and pH 7.4 gassed with 94% O 2 -6% CO 2 . Isometric tension was recorded continuously.
FIGURE 1. Effects and mechanisms of action of pharmacological agents used to study contractions to
The arteries were allowed to stabilize at a resting tension of 200-400 mg for 1 hour. Each ring was then gradually stretched to the optimal point of its lengthtension curve as determined by the contraction to 10" 5 M uridine 5'-triphosphate (UTP) ( Table I) . 10 The endothelium was removed mechanically by gentle rubbing of the intimal surface with a 31-gauge stainless steel wire. 11 The absence of endothelium was confirmed by the absence of relaxations to 10~7 M vasopressin.
11
- 13 At the end of the experiments, the arteries were examined under light microscopy using polychromatic staining to confirm the absence of endothelial cells.
A radioimmunoassay technique was used to determine the levels of cyclic GMP.
14 Rings without endothelium were initially incubated in control solution bubbled with a 94% O 2 -6% O 2 gas mixture and Values are mean±SEM; n, number of dogs.
•Difference between control and treated rings is statistically significant (p<0.05). kept at 37°C. After 1 hour, the rings were incubated for an additional 30 minutes in a fresh solution containing 10~5 M indomethacin and 10" 4 M 3-isobutyl-1-methylxanthine (IBMX) to inhibit, respectively, the production of prostanoids and the degradation of cyclic nucleotides by phosphodiesterases. When L-NMMA was used to inhibit nitric oxide synthase(s) this, too, was present throughout the incubation period of 30 minutes; the activator of guanylate cyclase molsidomine (SIN-1) was added after 20 minutes of incubation and was in contact with the tissue for the remaining 10 minutes. After 30 minutes, the rings were removed from the solution and frozen in liquid nitrogen. A cyclic GMP radioimmunoassay kit (Amersham, Arlington Heights, 111.) was used to perform the measurements.
Concentration (-log M)
The following pharmacological agents were used: 8-arginine vasopressin (Sigma, St. Louis, Mo.), D-arginine hydrochloride (Sigma), L-arginine hydrochloride (Sigma), catalase (from bovine liver; 40,000 units/mg protein; Sigma), 9,ll-dideoxy-9a,lla-methanoepoxyprostaglandin F 2a (U46619; Cayman Chemical Co., Ann Arbor, Mich.), indomethacin (Sigma),
, papaverine hydrochloride (Sigma), pentobarbital sodium (Fort Dodge Laboratories Inc., Fort Dodge, Iowa), UTP (Sigma), xanthine (Sigma), xanthine oxidase (from buttermilk, chromatographically purified; Sigma), and zaprinast (M&B 22948, RhonePoulenc Rorer, Dagenham, UK).
Drugs were dissolved in distilled water such that volumes of <0.2 ml were added to the organ chambers. Stock solutions of 10~5 M indomethacin were 
2±0.3 g [n=6] for control and presence of L-arginine and D-arginine, respectively). Difference between control rings and L-arginine-treated rings is statistically significant (p<0.05).
prepared in equal-molar concentrations of Na 2 CO 3 . Xanthine was prepared in 10-ml stock solutions alkalized with 150 /il NaOH (IN). Stock solutions of 10~4 M zaprinast were prepared in dimethyl sulfoxide. These solvents do not affect the tone of unstimulated rings of canine basilar arteries. All concentrations are expressed as final molar bath concentrations. The incubation time was 30 minutes for indomethacin, 15 minutes for catalase plus xanthine plus xanthine oxidase, and 5 minutes for catalase and L-arginine and its analogues. Indomethacin and catalase plus xanthine plus xanthine oxidase increased resting tension, whereas L-arginine and D-arginine were without effect (Table 1) .
Concentration-response curves were obtained in a cumulative fashion. Several rings were cut from the same artery. Control and treated rings were studied in parallel; only one concentration-response curve was made per preparation. The contractions were expressed as a percentage of the maximal contractions induced by 60 mM KCl, whereas relaxations were expressed as a percentage of the maximal relaxations to 3 x 10~4 M papaverine. The EC 50 was calculated for each ring by linear interpolation between the two concentrations evoking responses just above and just below 50% of the maximum. For each series of experiments, the geometric mean and standard error of the values thus obtained are reported. 12 The results are expressed as mean±SEM; n refers to the number of dogs. The data were evaluated statistically using Student's / test for paired observations; p< 0.05 was considered to be significant.
Results
In quiescent rings 10" 6 to 3x10"" M L-NMMA caused concentration-dependent contractions. The effect of L-NMMA was significantly reduced by the removal of endothelium (maximal effect of 3 x 10" 4 M L-NMMA=38±4% and 15±3%, n=6 [p<0.05] for rings with and without endothelium, respectively). In rings without endothelium, 10~6 to 3xlO" 4 M D-NMMA did not affect resting tension (Figure 2) . At 10~3 M, L-arginine (but not D-arginine) significantly reduced contractions to L-NMMA (Figure 3) . Although the contractions to L-NMMA appear to be augmented in the presence of D-arginine, the difference between control and D-arginine-treated preparations was not significant. At 10" 7 to 3xlO" 4 M L-NNA caused small transient decreases in resting tension. This was not affected by L-arginine or D-arginine at 10" 3 M (Table 2 ).
Contractions to 10" 6 to 3x 10" 4 M L-NMMA were abolished in preparations exposed to superoxide anions generated by xanthine plus xanthine oxidase in the presence of catalase (Figure 4) . By contrast, contractions to the prostaglandin H^thromboxane A 2 
N -Monomethyl-L-Arginine (-log M)
receptor agonist U46619 at 10~1 0 to 10 6 M were not affected ( Figure 5 ).
During contractions induced by UTP, 1CT 7 to 10" 4 M zaprinast caused concentration-dependent relaxations. This effect was reduced significantly in a concentration-dependent manner by the presence of 10" 4 and 3xlO" 4 M L-NMMA ( Figure 6 ). At 10" 3 M L-arginine reversed the inhibitory effect of L-NMMA (Table 3) . By contrast, 10" 4 M L-NMMA did not affect significantly the relaxations to 10" 9 to 10~4 M SIN-1 (n=6; data not shown).
At 3 X 10~4 M L-NMMA significantly reduced the basal production of cyclic GMP. L-NMMA did not affect the production of cyclic GMP stimulated by 10" 4 M SIN-1 (Table 4) . - 20 The results of the present study indicate that contractions to L-NMMA can be best explained by inactivation of nitric oxide synthase(s) activity associated with decreased levels of cyclic GMP in vascular smooth muscle cells. This interpretation is favored by the fact that the effect of L-NMMA was stereospecific (D-NMMA was inactive) and inhibited by an excess of L-arginine but not D-arginine and supported by a decrease in the basal production of cyclic GMP in the presence of L-NMMA. The absence of an effect of L-NMMA on cyclic GMP production stimulated by the nitrovasodilator SIN-1 suggests that the inhibitory effect of L-NMMA is selective for the L-arginine-dependent generation of nitric oxide.
Discussion
L-NNA appears to be ineffective as an inhibitor of the basal activity of nitric oxide synthase in basilar arteries without endothelium. The rather small decrease in resting tension induced by high concentrations of L-NNA was not affected by L-arginine or D-arginine, suggesting that this is a nonspecific effect. Previous studies demonstrated that in peripheral ar- teries L-NNA is a much more potent inhibitor of endothelial nitric oxide synthase than L-NMMA. 3 This differential sensitivity to L-arginine analogues has been used as a criterion for characterization of constitutive nitric oxide synthase (higher sensitivity to L-NNA) versus inducible nitric oxide synthase (higher sensitivity to L-NMMA). 21 Taking into consideration this classification, the results of the present study would suggest that in cerebral arteries the nitric oxide synthase active under basal conditions is an inducible enzyme. Consistent with this concept would be the fact that the inducible enzyme, once activated, synthesizes nitric oxide at a constant rate for relatively long periods (5-36 hours). 22 In addition, it appears that in rat aorta the majority of the inducible enzyme is located in vascular smooth muscle cells. 23 However, the data presented do not allow a definite conclusion with regard to the type of enzyme involved. The differential sensitivity may simply reflect differences in the transport mechanisms for L-arginine analogues that operate in vascular smooth muscle cells. If this is the case, then differential reactivity can be explained by different access of L-arginine analogues to nitric oxide synthase. 24 Superoxide anions generated by xanthine plus xanthine oxidase in the presence of catalase cause contraction of canine basilar artery without endothelium. 13 This finding is confirmed in the present study. anions suggests that inhibition of the contractions to L-NMMA is not due to free radical-induced oxidative damage of the cerebral arterial wall. The inhibitory effect of superoxide anions is best explained by an inactivation of the nitric oxide produced under basal conditions. This explanation is consistent with the reported capability of superoxide anions to chemically inactivate nitric oxide.
2526
Relaxations of isolated arteries to zaprinast (a selective inhibitor of cyclic GMP phosphodiesterase) depend on the basal production of nitric oxide. 27 -28 This mechanism of relaxation would be consistent with the results of the present study, in which selective inhibition of relaxations to zaprinast was observed in the presence of the nitric oxide synthase(s) inhibitor L-NMMA. By contrast, relaxations to a donor of nitric oxide, SIN-1, do not depend on the activity of nitric oxide synthase and are mediated by the activation of guanylate cyclase. 29 This can explain the differential effect of L-NMMA on relaxations to zaprinast and SIN-1.
Nitric oxide synthase has been localized immunohistochemically in cerebral arterial nerves. 30 Furthermore, relaxations of cerebral arteries to stimulation of nonadrenergic noncholinergic nerves are inhibited by N°-substituted analogues of L-arginine. 31 -32 I cannot rule out the possibility that inhibition of the basal nitric oxide synthase activity in perivascular nerves may contribute to L-NMMA-induced contractions. It is also important to keep in mind that artificial conditions imposed on isolated arteries in vitro may induce the activity of nitric oxide synthase in smooth muscle cells. Therefore, further studies are needed to •Significantly different from control (p<0.05).
determine whether this mechanism may play a role in the regulation of cerebral arterial tone in vivo.
The results of the present study suggest that basal activity of nitric oxide synthase is present in vascular smooth muscle cells of the cerebral arteries. The physiological and pathophysiological importance of a biochemical pathway capable of producing nitric oxide or a closely related molecule in smooth muscle cells is not clear. However, in cerebral arteries this finding may help to explain the endothelium-independent component in contractions to hemoglobin and its possible contribution to the development of cerebral vasospasm.
